Is dementia on the decline? Research suggests it might be

by Allie Shah, Star Tribune (Minneapolis)Despite fears that the coming silver tsunami will trigger a dementia epidemic, a surprising new study suggests that it may be possible to delay - or even preve

Updated on: February 28,2024

Is dementia on the decline? Research suggests it might be

by Allie Shah, Star Tribune (Minneapolis)Despite fears that the coming silver tsunami will trigger a dementia epidemic, a surprising new study suggests that it may be possible to delay - or even preve

Updated on:February 28,2024

Alzheimer's disease: Five things to know

Credit: Unsplash/CC0 Public DomainAlzheimer's disease, a devastating neuro-degenerative condition that causes dementia, affects more than 30 million people worldwide and remains an illness for whi

Updated on: March 26,2024

Alzheimer's disease: Five things to know

Credit: Unsplash/CC0 Public DomainAlzheimer's disease, a devastating neuro-degenerative condition that causes dementia, affects more than 30 million people worldwide and remains an illness for whi

Updated on:March 26,2024

How Alzheimer's disease spreads throughout the brain – new study

by Thomas E Cope,The ConversationHarmful tau protein spreads through networks.Alzheimer's disease is a devastating brain illness that affects anestimated 47m peopleworldwide. It

Updated on: April 10,2024

How Alzheimer's disease spreads throughout the brain – new study

by Thomas E Cope,The ConversationHarmful tau protein spreads through networks.Alzheimer's disease is a devastating brain illness that affects anestimated 47m peopleworldwide. It

Updated on:April 10,2024

FDA approves much-debated Alzheimer's drug panned by experts

by Matthew PerroneIn this 2019 photo provided by Biogen, a researcher works on the development of the medication aducanumab in Cambridge, Mass. On Monday, June 7, 2021, the Food and Drug Administratio

Updated on: March 30,2024

FDA approves much-debated Alzheimer's drug panned by experts

by Matthew PerroneIn this 2019 photo provided by Biogen, a researcher works on the development of the medication aducanumab in Cambridge, Mass. On Monday, June 7, 2021, the Food and Drug Administratio

Updated on:March 30,2024

Pimavanserin reduced symptoms of dementia-related psychosis in phase 3 trial

by University of ExeterA large-scale trial has found a treatment with pimavanserin substantially reduced psychotic symptoms and reduced risk of relapse of those symptoms compared to placebo in pe

Updated on: March 07,2024

Pimavanserin reduced symptoms of dementia-related psychosis in phase 3 trial

by University of ExeterA large-scale trial has found a treatment with pimavanserin substantially reduced psychotic symptoms and reduced risk of relapse of those symptoms compared to placebo in pe

Updated on:March 07,2024

Precise map of primate foveolar cortex uncovers intricacies of brain's visual system

by Ingrid Fadelli , Medical XpressColor-coded responses to different visual stimuli. a, Activations to achromatic high-SF gratings (in cycles per degree). Yellow, SF11; purple, SF15; orange, SF18. b,

Updated on: January 14,2025

Precise map of primate foveolar cortex uncovers intricacies of brain's visual system

by Ingrid Fadelli , Medical XpressColor-coded responses to different visual stimuli. a, Activations to achromatic high-SF gratings (in cycles per degree). Yellow, SF11; purple, SF15; orange, SF18. b,

Updated on:January 14,2025

Early abnormalities of Alzheimer's disease: It takes two (proteins) to tango

by McGill UniversityCredit: McGill UniversityFor years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheim

Updated on: February 28,2024

Early abnormalities of Alzheimer's disease: It takes two (proteins) to tango

by McGill UniversityCredit: McGill UniversityFor years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheim

Updated on:February 28,2024

Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

by Alzheimer's Research UKCredit: Pixabay/CC0 Public DomainThe pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer's drug gantenerumab did not

Updated on: April 16,2024

Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

by Alzheimer's Research UKCredit: Pixabay/CC0 Public DomainThe pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer's drug gantenerumab did not

Updated on:April 16,2024

Brain exercise and training program to improve mind and body wellness in individuals with mild cognitive impairment

by Courtney Caprara,University of PittsburghIndividuals with mild cognitive impairment have a new resource in Pittsburgh with the recently establishedBrain Training and Exercise(BRiT

Updated on: March 07,2024

Brain exercise and training program to improve mind and body wellness in individuals with mild cognitive impairment

by Courtney Caprara,University of PittsburghIndividuals with mild cognitive impairment have a new resource in Pittsburgh with the recently establishedBrain Training and Exercise(BRiT

Updated on:March 07,2024

Dementia among overlooked conditions linked to high risk of severe COVID-19 in older people

by University of ExeterCredit: CC0 Public DomainA new analysis shows which certain pre-existing diseases may put older people at risk of developing more severe COVID-19, implying they may need sp

Updated on: May 11,2024

Dementia among overlooked conditions linked to high risk of severe COVID-19 in older people

by University of ExeterCredit: CC0 Public DomainA new analysis shows which certain pre-existing diseases may put older people at risk of developing more severe COVID-19, implying they may need sp

Updated on:May 11,2024

Identification of a central regulator

by Ludwig Maximilian University of MunichC1q (green) and ApoE (red) proteins form deposits in the choroid plexus, as the researchers revealed by super-resolution microscopy. Bar 1 µm. Credit: C.

Updated on: March 09,2024

Identification of a central regulator

by Ludwig Maximilian University of MunichC1q (green) and ApoE (red) proteins form deposits in the choroid plexus, as the researchers revealed by super-resolution microscopy. Bar 1 µm. Credit: C.

Updated on:March 09,2024

New indication of a link between Alzheimer's and diabetes

by Forschungszentrum JuelichIllustration of IAPP fibrils. Credit: Forschungszentrum Jülich/HHU Düsseldorf/Gunnar SchröderPathological protein clumps are characteristic of a series of diseases, su

Updated on: April 10,2024

New indication of a link between Alzheimer's and diabetes

by Forschungszentrum JuelichIllustration of IAPP fibrils. Credit: Forschungszentrum Jülich/HHU Düsseldorf/Gunnar SchröderPathological protein clumps are characteristic of a series of diseases, su

Updated on:April 10,2024